312 related articles for article (PubMed ID: 30036569)
1. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
Ge F; Ding J; Liu Y; Lin H; Chang T
Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
[TBL] [Abstract][Full Text] [Related]
3. Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O; Janelidze S; Hall S; Magdalinou N; Lees AJ; Andreasson U; Norgren N; Linder J; Forsgren L; Constantinescu R; Zetterberg H; Blennow K;
Neurology; 2017 Mar; 88(10):930-937. PubMed ID: 28179466
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
Hu X; Yang Y; Gong D
Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
[TBL] [Abstract][Full Text] [Related]
5. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B
Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470
[TBL] [Abstract][Full Text] [Related]
6. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
7. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
[TBL] [Abstract][Full Text] [Related]
8. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
[TBL] [Abstract][Full Text] [Related]
10. Serum NFL discriminates Parkinson disease from atypical parkinsonisms.
Marques TM; van Rumund A; Oeckl P; Kuiperij HB; Esselink RAJ; Bloem BR; Otto M; Verbeek MM
Neurology; 2019 Mar; 92(13):e1479-e1486. PubMed ID: 30814322
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
[TBL] [Abstract][Full Text] [Related]
13. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
14. Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.
Santaella A; Kuiperij HB; van Rumund A; Esselink RAJ; van Gool AJ; Bloem BR; Verbeek MM
BMC Neurol; 2020 Jan; 20(1):26. PubMed ID: 31952511
[TBL] [Abstract][Full Text] [Related]
15. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
Holmberg B; Johnels B; Ingvarsson P; Eriksson B; Rosengren L
Parkinsonism Relat Disord; 2001 Sep; 8(1):23-31. PubMed ID: 11472877
[TBL] [Abstract][Full Text] [Related]
16. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again.
Compta Y; Painous C; Soto M; Pulido-Salgado M; Fernández M; Camara A; Sánchez V; Bargalló N; Caballol N; Pont-Sunyer C; Buongiorno M; Martin N; Basora M; Tio M; Giraldo DM; Pérez-Soriano A; Zaro I; Muñoz E; Martí MJ; Valldeoriola F
Parkinsonism Relat Disord; 2022 Jun; 99():33-41. PubMed ID: 35594661
[TBL] [Abstract][Full Text] [Related]
17. Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.
Borm CDJM; Krismer F; Wenning GK; Seppi K; Poewe W; Pellecchia MT; Barone P; Johnsen EL; Østergaard K; Gurevich T; Djaldetti R; Sambati L; Cortelli P; Petrović I; Kostić VS; Brožová H; Růžička E; Marti MJ; Tolosa E; Canesi M; Post B; Nonnekes J; Bloem BR;
Parkinsonism Relat Disord; 2018 Nov; 56():33-40. PubMed ID: 29910157
[TBL] [Abstract][Full Text] [Related]
18. Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study.
Painous C; Pascual-Diaz S; Muñoz-Moreno E; Sánchez V; Pariente JC; Prats-Galino A; Soto M; Fernández M; Pérez-Soriano A; Camara A; Muñoz E; Valldeoriola F; Caballol N; Pont-Sunyer C; Martin N; Basora M; Tio M; Rios J; Martí MJ; Bargalló N; Compta Y
Eur Radiol; 2023 Jul; 33(7):4540-4551. PubMed ID: 36773046
[TBL] [Abstract][Full Text] [Related]
19. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
Jabbari E; Woodside J; Guo T; Magdalinou NK; Chelban V; Athauda D; Lees AJ; Foltynie T; Houlden H; Church A; Hu MT; Rowe JB; Zetterberg H; Morris HR
J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):768-773. PubMed ID: 30867224
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.
Magdalinou NK; Noyce AJ; Pinto R; Lindstrom E; Holmén-Larsson J; Holtta M; Blennow K; Morris HR; Skillbäck T; Warner TT; Lees AJ; Pike I; Ward M; Zetterberg H; Gobom J
Parkinsonism Relat Disord; 2017 Apr; 37():65-71. PubMed ID: 28214264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
